Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of temsirolimus plus letrozole versus letrozole alone as first-line hormonal therapy in postmenopausal women with advanced or metastatic breast cancer
2004-000015-25Phase 3Completed
- Sponsor
- Wyeth
- Start
- Jun 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Temsirolimus + letrozole with Letrozole + placebo (2 arms). Primary endpoint: Overall progression-free survival. Started Jun 2004; status: completed.
02
Drugs
temsirolimusletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-000015-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000015-25.